📰 Nasdaq Gnom News
Nasdaq Gnom News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Gnom. Real-time updates on events, politics, business and more.
October 10, 2023
James J. Burns & Company LLC increased its position in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) by 8.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,939 shares of the company’s stock after […]
September 29, 2023
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Free Report) was the recipient of a large decline in short interest in September. As of September 15th, there was short interest totalling 15,500 shares, a decline of 95.9% from the August 31st total of 374,700 shares. Based on an average daily trading volume, of 189,100 […]
July 3, 2023
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 47,100 shares, a drop of 32.2% from the May 31st total of 69,500 shares. Based on an average trading volume of 78,300 shares, the […]
June 14, 2023
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) saw a large increase in short interest in May. As of May 31st, there was short interest totalling 69,500 shares, an increase of 100.9% from the May 15th total of 34,600 shares. Based on an average daily trading volume, of 83,800 shares, the days-to-cover ratio […]
June 9, 2023
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $12.43 and traded as high as $12.94. Global X Genomics & Biotechnology ETF shares last traded at $12.87, with a volume of 32,679 shares traded. Global […]
April 18, 2023
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 102,800 shares, a growth of 139.6% from the March 15th total of 42,900 shares. Based on an average trading volume of 95,400 shares, the […]
April 16, 2023
Portland Global Advisors LLC lifted its holdings in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) by 2.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,133 shares of the company’s stock after buying an additional 5,093 […]
May 29, 2022
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 39,600 shares, a decline of 44.2% from the April 30th total of 71,000 shares. Based on an average daily volume of […]
May 28, 2022
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) was the recipient of a large decrease in short interest in May. As of May 15th, there was short interest totalling 39,600 shares, a decrease of 44.2% from the April 30th total of 71,000 shares. Based on an average daily volume of 179,700 shares, the […]
May 16, 2022
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Get Rating) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 71,000 shares, a growth of 30.3% from the April 15th total of 54,500 shares. Based on an average daily volume of 100,600 shares, the short-interest ratio is […]